UBS Group’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-9
| Closed | -$45 | – | 9086 |
|
|
2024
Q1 | $45 | Sell |
9
-359
| -98% | -$1.8K | ﹤0.01% | 7769 |
|
|
2023
Q4 | $2.49K | Buy |
368
+366
| +18,300% | +$2.47K | ﹤0.01% | 6889 |
|
|
2023
Q3 | $18 | Buy |
+2
| New | +$18 | ﹤0.01% | 7995 |
|
|
2023
Q2 | – | Sell |
-453
| Closed | -$12.2K | – | 7694 |
|
|
2023
Q1 | $12.2K | Sell |
453
-75
| -14% | -$2.02K | ﹤0.01% | 6362 |
|
|
2022
Q4 | $18.7K | Buy |
528
+365
| +224% | +$12.9K | ﹤0.01% | 6543 |
|
|
2022
Q3 | $37K | Sell |
163
-57
| -26% | -$12.9K | ﹤0.01% | 5568 |
|
|
2022
Q2 | $42K | Sell |
220
-220
| -50% | -$42K | ﹤0.01% | 5051 |
|
|
2022
Q1 | $110K | Buy |
440
+4
| +0.9% | +$1K | ﹤0.01% | 4846 |
|
|
2021
Q4 | $68K | Buy |
436
+310
| +246% | +$48.3K | ﹤0.01% | 5564 |
|
|
2021
Q3 | $25K | Buy |
126
+48
| +62% | +$9.52K | ﹤0.01% | 5804 |
|
|
2021
Q2 | $20K | Sell |
78
-3
| -4% | -$769 | ﹤0.01% | 6259 |
|
|
2021
Q1 | $22K | Sell |
81
-2,855
| -97% | -$775K | ﹤0.01% | 6288 |
|
|
2020
Q4 | $1.08M | Buy |
2,936
+280
| +11% | +$103K | ﹤0.01% | 3095 |
|
|
2020
Q3 | $648K | Sell |
2,656
-337
| -11% | -$82.2K | ﹤0.01% | 3215 |
|
|
2020
Q2 | $862K | Buy |
2,993
+710
| +31% | +$204K | ﹤0.01% | 2940 |
|
|
2020
Q1 | $466K | Buy |
2,283
+1,372
| +151% | +$280K | ﹤0.01% | 3270 |
|
|
2019
Q4 | $407K | Buy |
911
+341
| +60% | +$152K | ﹤0.01% | 4060 |
|
|
2019
Q3 | $175K | Buy |
570
+553
| +3,253% | +$170K | ﹤0.01% | 4455 |
|
|
2019
Q2 | $5K | Hold |
17
| – | – | ﹤0.01% | 6524 |
|
|
2019
Q1 | $7K | Sell |
17
-55
| -76% | -$22.6K | ﹤0.01% | 6194 |
|
|
2018
Q4 | $22K | Buy |
72
+41
| +132% | +$12.5K | ﹤0.01% | 5792 |
|
|
2018
Q3 | $11K | Buy |
31
+14
| +82% | +$4.97K | ﹤0.01% | 6208 |
|
|
2018
Q2 | $6K | Sell |
17
-36
| -68% | -$12.7K | ﹤0.01% | 6499 |
|
|
2018
Q1 | $16K | Buy |
53
+2
| +4% | +$604 | ﹤0.01% | 5699 |
|
|
2017
Q4 | $21K | Buy |
51
+50
| +5,000% | +$20.6K | ﹤0.01% | 5562 |
|
|
2017
Q3 | $0 | Sell |
1
-1
| -50% | – | ﹤0.01% | 6950 |
|
|
2017
Q2 | $0 | Sell |
2
-51
| -96% | – | ﹤0.01% | 6917 |
|
|
2017
Q1 | $18K | Buy |
53
+25
| +89% | +$8.49K | ﹤0.01% | 5306 |
|
|
2016
Q4 | $10K | Buy |
28
+4
| +17% | +$1.43K | ﹤0.01% | 5971 |
|
|
2016
Q3 | $10K | Buy |
+24
| New | +$10K | ﹤0.01% | 5880 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 6962 |
|
|
2016
Q1 | – | Sell |
-3
| Closed | -$2K | – | 6926 |
|
|
2015
Q4 | $2K | Buy |
+3
| New | +$2K | ﹤0.01% | 6607 |
|
|
2015
Q3 | – | Sell |
-33
| Closed | -$18K | – | 6990 |
|
|
2015
Q2 | $18K | Buy |
33
+31
| +1,550% | +$16.9K | ﹤0.01% | 5586 |
|
|
2015
Q1 | $17K | Hold |
2
| – | – | ﹤0.01% | 5514 |
|
|
2014
Q4 | $18K | Buy |
+2
| New | +$18K | ﹤0.01% | 5637 |
|